These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9463023)

  • 21. Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
    Geary RS; Bradley JD; Watanabe T; Kwon Y; Wedel M; van Lier JJ; VanVliet AA
    Clin Pharmacokinet; 2006; 45(8):789-801. PubMed ID: 16884318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus.
    Chung M; Kourides I; Canovatchel W; Sutfin T; Messig M; Chaiken RL
    J Clin Pharmacol; 2002 Jun; 42(6):651-7. PubMed ID: 12043953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quality of life and non-insulin-dependent diabetes].
    Tauber JP
    Diabetes Metab; 1997 Nov; 23 Suppl 4():44-8. PubMed ID: 9463024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
    Mutalik S; Udupa N
    Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of sulfonylureas: a brief review.
    Melander A; Wåhlin-Boll E
    Ann Clin Res; 1983; 15 Suppl 37():12-5. PubMed ID: 6679185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.
    Scheen AJ
    Diabetes Obes Metab; 2010 Aug; 12(8):648-58. PubMed ID: 20590741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of sulphonylureas in the elderly.
    Graal MB; Wolffenbuttel BH
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparison between glibenclamide and glipizide in the treatment of type II diabetes].
    Shi MZ; Feng JG; Zheng JJ
    Zhonghua Nei Ke Za Zhi; 1991 Feb; 30(2):94-7, 126. PubMed ID: 1907539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From the concept of fast acting analogs to the properties of the insulin Lispro].
    Selam JL
    Diabetes Metab; 1997 Sep; 23 Suppl 3():45-9. PubMed ID: 9410552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a concentration-effect relationship for sulphonylureas?
    Melander A; Donnelly R; Rydberg T
    Clin Pharmacokinet; 1998 Mar; 34(3):181-8. PubMed ID: 9533980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v.
    Guirgis FK; Ghanem MH; Abdel-Hay MM
    Arzneimittelforschung; 1976; 26(3):435-7. PubMed ID: 134717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
    Burge MR; Schmitz-Fiorentino K; Sood V; Schade DS
    JAMA; 1999 Mar 24-31; 281(12):1084-5. PubMed ID: 10188656
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
    Balant L; Fabre J; Zahnd GR
    Eur J Clin Pharmacol; 1975; 8(1):63-9. PubMed ID: 823030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing.
    Kradjan WA; Kobayashi KA; Bauer LA; Horn JR; Opheim KE; Wood FJ
    J Clin Pharmacol; 1989 Dec; 29(12):1121-7. PubMed ID: 2693502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Synthesis of Glipizide and Glibenclamide in Continuous Flow.
    Sagandira CR; Khasipo AZ; Watts P
    Chemistry; 2021 Nov; 27(64):16028-16035. PubMed ID: 34633700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.